Overview

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma

Status:
TERMINATED

Trial end date:
2025-01-20

Target enrollment:

Participant gender:

Summary

A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI® Surgical System Compared to Standard Medical Treatment as a Standalone Procedure in Patients with Primary Open Angle Glaucoma (EVOLVE)

Phase:

PHASE4

Details

Lead Sponsor:

Sight Sciences, Inc.

Treatments:

Latanoprost